•
Dec 31, 2018

PTC Therapeutics Q4 2018 Earnings Report

Total Revenue
$86.3M
Previous year: $78M
+10.6%
EPS
-$0.58
Previous year: $0.03
-2033.3%
R&D Expenses
$53.6M
SG&A Expenses
$48.7M
Net Loss
-$48.3M
Gross Profit
$82.6M
Previous year: $75.6M
+9.2%
Cash and Equivalents
$169M
Previous year: $112M
+51.6%
Free Cash Flow
-$19.8M
Previous year: $19.2M
-202.6%
Total Assets
$1.12B
Previous year: $392M
+185.8%

PTC Therapeutics

PTC Therapeutics